Physiological correlates of HIV-related fatigue

Clinical Nursing Research

Volumn 17, Issue 1, 2008, Pages 5-19

  Barroso, Julie ^a,c   Pence, Brian Wells ^a   Salahuddin, Naima ^a   Harmon, James L ^a   Leserman, Jane ^b  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarkers; HIV related fatigue; Physiological variables

Indexed keywords

BILIRUBIN; HYDROCORTISONE; TESTOSTERONE; THYROXINE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; BLOOD; CASE CONTROL STUDY; FATIGUE; FEMALE; HEMATOCRIT; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR SYSTEM; NURSING RESEARCH; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL MODEL; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ATTITUDE TO HEALTH; BILIRUBIN; CASE-CONTROL STUDIES; FATIGUE; FEMALE; HEMATOCRIT; HIV SEROPOSITIVITY; HUMANS; HYDROCORTISONE; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; NURSING RESEARCH; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TESTOSTERONE; THYROXINE; VIRAL LOAD;

EID: 37649024553     PISSN: 10547738     EISSN: 15523799     Source Type: Journal    
DOI: 10.1177/1054773807311382     Document Type: Article

References (50)

1. Aaronson, L.S., Teel, C.S., Cassmeyer, V., Neuberger, G.B., Pallikkathayil, L., Pierce, J., et al. (1999). Defining and measuring fatigue. IMAGE: Journal of Nursing Scholarship, 31, 45-50.
2. Andersen, A.B., Law, I., Ostrowski, S.R.,. Lebech, A.M., Hoyer-Hansen, G., Hojgaard, L., et al. (2006). Self-reported fatigue common among optimally treated HIV patients: No correlation with cerebral FDG-PET scanning abnormalities. Neuroimmunomodulation, 13, 69-75.
3. Barroso, J., Carlson, J.R., & Meynell, J. (2003). Physiological and psychological markers associated with HIV-related fatigue. Clinical Nursing Research, 12 (1). 49-68.
4. Barroso, J., & Lynn, M.R. (2002). Psychometric properties of the HIV-Related Fatigue Scale. Journal of the Association of Nurses in AIDS Care, 13, 66-75.
5. Bartlett, J.G., & Gallant, J.E. (2000). Medical management of HIV infection (2 nd ed.). Baltimore, MD: Johns Hopkins University.
6. Bofill, M., & Borthwick, N.J. (2000). CD38 in health and disease. Chemical Immunology, 75, 218-234.
7. Braitstein, P., Montessori, V., Chan, K., Montaner, J.S.G., Schechter, M.T., O'Shaughnessy, M.V., et al. (2005). Quality of life, depression, and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort. AIDS Care, 17, 505-515.
8. Breitbart, W., McDonald, M.V., Rosenfeld, B., Monkman, N.D., & Passik, S. (1998). Fatigue in ambulatory AIDS patients. Journal of Pain and Symptom Management, 15, 159-167.
9. Chun, T-W., Justement, J.S., Sanford, C., Hallahan, C.W., Planta, M.A., Loutfy, M., et al. (2004). Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. Proceedings of the National Academy of Sciences of the United States of America, 101, 2464-2469.
10. Clerici, M., Galli, M., Bosis, S., Gervasoni, C., Moroni, M., & Norbiato, G. (2000). Immunoendocrinologic abnormalities in human immunodeficiency virus infection. Annals of the New York Academy of Sciences, 917, 956-961.
11. Clerici, M., Trabattoni, D., Piconi, S., Fusi, M.L., Ruzzante, S., Clerici, C., et al. (1997). A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology, 22 (suppl 1). S27 - S31.
12. Darko, D.F., McCutchan, J.A., Kripke, D.F., Gillin, J.C., & Golshan, S. (1992). Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. American Journal of Psychiatry, 149, 514-520.
13. Deterre, P., Berthelier, V., Bauvois, B., Dalloul, A., Schuber, F., & Lund, F. (2000). CD38 in T- and B-cell functions. Chemical Immunology, 75, 146-68.
14. Eledrisi, M.S., & Verghese, A.C. (2001). Adrenal insufficiency in HIV infection: a review and recommendations. American Journal of the Medical Sciences, 321, 137-144.
15. Enwonwu, C.O., Meeks, V.I., & Sawiris, P.G. (1996). Elevated cortisol levels in whole saliva in HIV infected individuals. European Journal of Oral Sciences, 104, 322-324.
16. Ferrando, S., Evans, S., Goggin, K., Sewell, M., Fishman, B., & Rabkin, J. (1998). Fatigue in HIV illness: Relationship to depression, physical limitations, and disability. Psychosomatic Medicine, 60, 759-764.
17. Ferri, R.S. (2002). Challenges in managing the HIV and HCV co-infected patient. Symposium presented at the 14th Annual Conference of the Association of Nurses in AIDS Care, Minneapolis, MN.
18. Ferri, R.S., Adinolfi, A., Orsi, A.J., Sterken, D.J., Keruly, J.C., Davis, S., et al. (2001). Treatment of anemia in patients with HIV infection, Part 1: The need for adequate guidelines. Journal of the Association of Nurses in AIDS Care, 12 (6). 39-51.
19. Groopman, J.E. (1998). Fatigue in cancer and HIV/AIDS. Oncology, 12, 335-344.
20. Henderson, M., Safa, F., Easterbrook, P., & Hotopf, M. (2005). Fatigue among HIV-infected patients in the era of highly active antiretroviral therapy. HIV Medicine, 6, 347-352.
21. Justice, A.C., Rabeneck, L., Hays, R.D., Wu, A.W., & Bozzette, S.A. (1999). Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms. Journal of Acquired Immune Deficiency Syndromes (JAIDS). 21, 126-133.
22. Kirschbaum, C., & Hellhammer, D.H. (1994). Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology, 19, 313-333.
23. Kirton, C.A. (2002). Anemia: Prevalence and causes in HIV and HCV. Symposium presented at the 14th Annual Conference of the Association of Nurses in AIDS Care, Minneapolis, MN.
24. Knapp, S., Lenz, P., Gerlitz, S., Rieger, A., Meier, S., & Stingl, G. (2001). Highly active antiretroviral therapy responders exhibit a phenotypic lymphocyte pattern comparable to that of long-term nonprogressors. International Archives of Allergy & Immunology, 126, 248-256.
25. Koch, J., Kim, L.S., & Friedman, S. (2001). Gastrointestinal manifestations of HIV disease. In L. Peiperl & P. A. Volberding (Eds.), The AIDS knowledge base. Available online at http://hivinsite.ucsf.edu/InSite.jsp? page=kb-04-01-11#S1X
26. Lee, K.A., Portillo, C.J., & Miramontes, H. (1999). The fatigue experience for women with Human Immunodeficiency Virus. JOGNN, 28, 193-200.
27. Li, L., Wei, F-L., Mei, S., Feng, X., Yao, J., Jin, X., et al. (2004). Virological and immunological outcomes in HIV-1-infected Chinese patients treated with a combination of efavirenz and indinavir for 48 weeks. Chinese Medical Journal, 117, 347-352.
28. Mocroft, A., Kirk, O., Barton, S.E., Dietrich, M., Proenca, R., Colebunders, R., et al. (1999). Anemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. For the EuroSIDA Study Group. AIDS, 13, 943-950.
29. Moore, R.D. (1999). Human immunodeficiency virus infection, anemia, and survival. Clinical Infectious Diseases, 29, 44-49.
30. Moore, R.D., Keruly, J.C., & Chaisson, R.E. (1998). Anemia and survival in HIV infection. AIDS, 19, 29-33.
31. Patarca-Montero, R., Antoni, M., Fletcher, M.A., & Klimas, N.G. (2001). Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Applied Neuropsychology, 8, 51-64.
32. Perkins, D.O., Leserman, J., Stern, R.A., Baum, S.F., Liao, D., Golden, R.N., & Evans, D.L. (1995). Somatic symptoms and HIV infection: Relationship to depressive symptoms and indicators of HIV disease. American Journal of Psychiatry, 152, 1776-1781.
33. Piedrola, G., Casado, J.L., Lopez, E., Moreno, A., Perez-Elias, M.J., & Garcia-Robles, R. (1996). Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome. Clinical Endocrinology, 45, 97-101.
34. Rabkin, J.G., Ferrando, S.J., Wagner, G.J., & Rabkin, R. (2000). DHEA treatment for HIV+ patients: Effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology, 25, 53-68.
35. Rabkin, J.G., Wagner, G.J., & Rabkin, R. (2000). A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms. Archives of General Psychiatry, 57, 141-147.
36. Rondanelli, M., Solerte, S.B., Fioravanti, M., Scevola, D., Locatelli, M., Minoli, L., et al. (1997). Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection. AIDS Research and Human Retroviruses, 13, 1243-1249.
37. Savarino, A., Bottarel, F., Malavasi, F., & Dianzani, U. (2000). Role of CD38 in HIV-1 infection: An epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS, 14, 1079-1089.
38. Schurmeyer, T.H., Muller, V., Muhlen, A., & Schmidt, R.E. (1997). Thyroid and adrenal function in HIV-infected outpatients. European Journal of Medical Research, 2, 220-226.
39. Semba, R.D., Martin, B.K., Kempen, J.H., Thorne, J.E., & Wu, A.W. (2005). The impact of anemia on energy and physical functioning in individuals with AIDS. Archives of Internal Medicine, 165, 2229-2236.
40. Simmonds, M.J., Novy, D., & Sandoval, R. (2005). The differential influence of pain and fatigue on physical performance and health status in ambulatory patients with human immunodeficiency virus. Clinical Journal of Pain, 21, 200-206.
41. Stolarczyk, R., Rubio, S.I., Smolyar, D., Young, I.S., & Poretsky, L. (1998). Twenty-four-hour urinary free cortisol in patients with acquired immunodeficiency syndrome. Metabolism, 47, 690-694.
42. Stuart, J.W.T.C., Hazebergh, M.D., Hamann, D., Otto, S.A., Borleffs, J.C.C., Miedema, F., et al. (2000). The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation. JAIDS, 25, 203-211.
43. Sullivan, P., Dworkin, M.S., & the Adult and Adolescent Spectrum of HIV Disease Investigators. (2003). Prevalence and correlates of fatigue among persons with HIV infection. Journal of Pain and Symptom Management, 25, 329-333.
44. Sullivan, P.S., Hanson, D.L., Chu, S.Y., Jones, J.L., Ward, J.W., & the Adult/Adolescent Spectrum of Disease Group. (1998). Epidemiology of anemia in Human Immunodeficiency Virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood, 91, 301-308.
45. Teitelbaum, J.E., Bird, B., Greenfield, R.M., Weiss, A., Muenz, L., & Gould, L. (2001). Effective treatment of chronic fatigue syndrome and fibromyalgia-A randomized, double-blind, placebo-controlled, intent-to-treat study. Journal of Chronic Fatigue Syndrome, 8 (2). 3-28.
46. Vigano, A., Saresella, M., Villa, M.L., Ferrante, P., & Clerici, M. (2000). CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals. Chemical Immunology, 75, 207-217.
47. Vlahov, D., Munoz, A., Solomon, L., Astemborski, J., Lindsay, A., Anderson, J., et al. (1994). Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS, 8, 819-823.
48. Vogl, D., Rosenfeld, B., Breitbart, W., Thaler, H., Passik, S., McDonald, M., et al. (1999). Symptom prevalence, characteristics and distress in AIDS outpatients. Journal of Pain and Symptom Management, 19, 253-262.
49. Voss, J.G. (2002). Predictors and correlates of fatigue in African-Americans with HIV/AIDS. Paper presented at the 15th Annual Conference of the Association of Nurses in AIDS Care, San Francisco, CA.
50. Walker, K., McGown, A., Jantos, M., & Anson, J. (1997). Fatigue, depression and quality of life in HIV-positive men. Journal of Psychosocial Nursing, 35, 32-40.